A lung-brain inflammation connection

Elderly woman with gray hair in white turtleneck gazing thoughtfully out a window

Researchers have discovered that the inflammation related to pulmonary hypertension can damage the brain and lead to cognitive impairment.

  • Pulmonary hypertension triggers inflammatory processes that damage specific brain regions including the cerebellum and frontal lobe, affecting memory and concentration.
  • The NCOA7 gene variant drives inflammation in approximately 25% of pulmonary hypertension patients and worsens survival outcomes.
  • Brain imaging revealed significant tissue loss and poor communication between brain regions in patients with pulmonary hypertension compared to healthy individuals.
  • A biological marker could help identify patients at risk of cognitive decline, but current treatment guidelines do not include cognitive screening.

Researchers from the University of Pittsburgh and UPMC in Pennsylvania have identified a new connection between pulmonary hypertension (PH) and cognitive impairment. The study, “Cerebellar and Frontal Lobe Alterations in Pulmonary Hypertension Implicate an Inflammatory Lung Vascular/Brain Axis,” was published in the Journal of Clinical Investigation.

The study found an association between inflammatory processes that drive disease in the lungs and heart and specific brain abnormalities, which can produce cognitive decline. The findings also suggest that a biological marker could help detect people who may be at risk of cognitive issues, the researchers said.

“This changes the way we look at a disease like pulmonary hypertension,” said Stephen Chan, MD, Vitalant Professor of Vascular Medicine at Pitt School of Medicine. “In medicine, we typically treat the symptoms of one organ system, but the reality is our bodies are very complex, and disease processes may be affecting many parts of the body in a variety of ways.”

Dr. Chan is also director of the Vascular Medicine Institute and the Center for Pulmonary Vascular Biology and Medicine at Pitt School of Medicine and UPMC. In prior research, he had identified a variant of the gene NCOA7 that drives inflammatory responses and worsens survival changes in approximately 25% of PH patients. At the time, Dr. Chan believed the variant could be related to brain inflammation that causes cognitive dysfunction in patients who have PH.

In the new study, Dr. Chan tested this theory using magnetic resonance imaging (MRI) scans and blood tests to look for changes in the brain that were unique to PH. The research team compared brain scans of people with the chronic disease to those without, drawing on data from a large public health database as well as a smaller cohort of UPMC patients.

In both test groups, researchers reported that patients with PH showed a consistent and significant decrease of brain tissue as well as poor communication between the cerebellum and the frontal lobe — two brain regions involved in memory, attentiveness and organization.

To validate their findings, the team conducted additional laboratory tests and analyzed genetic data from both groups of patients. The authors determined that NCOA7 was linked to both inflammation in the cerebellum and blood vessel inflammation in patients with PH. They also said the mechanism could be active in other inflammatory and vascular conditions.

“I believe that NCOA7 deficiency may underlie a spectrum of inflammatory conditions — including those that may contribute to dementia and aging,” Dr. Chan said. “If so, these findings could introduce new diagnostic and therapeutic avenues for preserving brain function in a much broader group for people.”

Current pulmonary hypertension management guidelines do not include a recommendation for cognitive screening. They also do not cite any biomarkers to help predict risk or track progress of the disease’s impact on the brain. Dr. Chan said the study demonstrates the potential of a biological marker and identifies inflammation as a possible therapeutic target for preserving brain function and cognition-related quality of life.

“Patients often assume memory issues or trouble concentrating are unrelated to their pulmonary hypertension,” Dr. Chan said. “Our findings suggest those symptoms are a central part of the disease process and deserve attention.”

More in Pulmonary
Page 1 of 30
Next Page